scholarly journals The Effects of Mediterranean Diet on the Human Gut Microbiota; a Brief Discussion of Evidence in Humans

2021 ◽  
Vol 5 (1) ◽  
Author(s):  
Anita H Kelleher ◽  
Angelos K Sikalidis ◽  
Keyword(s):  
Gut Microbiota ◽  
Mediterranean Diet ◽  
Metabolic Diseases ◽  
Short Chain Fatty Acids ◽  
Gut Health ◽  
Omega 3 ◽  
Bioactive Components ◽  
Human Gut ◽  
The Mediterranean

The Mediterranean diet (MD) is considered one of the healthiest dietary patterns due to its rich provision of phytochemicals, antioxidants, vitamins, fiber, polyunsaturated, omega-3, and short-chain fatty acids through a variety of foods. The supply of such nutrients and bioactive components can support gut health and reduce systemic inflammation, with accumulating evidence from several human studies demonstrating the utility of the Mediterranean diet in the prevention of chronic and metabolic diseases. Further studies are needed to explore the role of the Mediterranean diet protecting against such diseases and the related mechanisms, including the interplay between components of the MD and gut microbiota. This brief systematic review specifically explores the recent evidence in humans investigating the link between MD and the human microbiota. Herein, over 50 articles were revised and referenced, after a careful vetting process, to produce this manuscript. Articles were ultimately selected based upon the detail and novelty of their content and contribution to the field.

scholarly journals MECHANISMS IN ENDOCRINOLOGY: Gut microbiota in patients with type 2 diabetes mellitus

2015 ◽  
Vol 172 (4) ◽  
pp. R167-R177 ◽  
Author(s):  
Kristine H Allin ◽  
Trine Nielsen ◽  
Oluf Pedersen
Keyword(s):  
Type 2 Diabetes ◽  
Gut Microbiota ◽  
Metabolic Diseases ◽  
Short Chain Fatty Acids ◽  
Intestinal Content ◽  
Low Grade ◽  
Bacterial Fermentation ◽  
Underlying Mechanisms

Perturbations of the composition and function of the gut microbiota have been associated with metabolic disorders including obesity, insulin resistance and type 2 diabetes. Studies on mice have demonstrated several underlying mechanisms including host signalling through bacterial lipopolysaccharides derived from the outer membranes of Gram-negative bacteria, bacterial fermentation of dietary fibres to short-chain fatty acids and bacterial modulation of bile acids. On top of this, an increased permeability of the intestinal epithelium may lead to increased absorption of macromolecules from the intestinal content resulting in systemic immune responses, low-grade inflammation and altered signalling pathways influencing lipid and glucose metabolism. While mechanistic studies on mice collectively support a causal role of the gut microbiota in metabolic diseases, the majority of studies in humans are correlative of nature and thus hinder causal inferences. Importantly, several factors known to influence the risk of type 2 diabetes, e.g. diet and age, have also been linked to alterations in the gut microbiota complicating the interpretation of correlative studies. However, based upon the available evidence, it is hypothesised that the gut microbiota may mediate or modulate the influence of lifestyle factors triggering development of type 2 diabetes. Thus, the aim of this review is to critically discuss the potential role of the gut microbiota in the pathophysiology and pathogenesis of type 2 diabetes.

scholarly journals Human Gut Microbiota in Health and Selected Cancers

2021 ◽  
Vol 22 (24) ◽  
pp. 13440
Author(s):  
Aleksandra Sędzikowska ◽  
Leszek Szablewski
Keyword(s):  
Gut Microbiota ◽  
Metabolic Diseases ◽  
Human Gut ◽  
Vast Number ◽  
Human Gut Microbiota ◽  
Internal And External Factors ◽  
Number Of Bacteria ◽  
Gut Microbiota Dysbiosis

The majority of the epithelial surfaces of our body, and the digestive tract, respiratory and urogenital systems, are colonized by a vast number of bacteria, archaea, fungi, protozoans, and viruses. These microbiota, particularly those of the intestines, play an important, beneficial role in digestion, metabolism, and the synthesis of vitamins. Their metabolites stimulate cytokine production by the human host, which are used against potential pathogens. The composition of the microbiota is influenced by several internal and external factors, including diet, age, disease, and lifestyle. Such changes, called dysbiosis, may be involved in the development of various conditions, such as metabolic diseases, including metabolic syndrome, type 2 diabetes mellitus, Hashimoto’s thyroidis and Graves’ disease; they can also play a role in nervous system disturbances, such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and depression. An association has also been found between gut microbiota dysbiosis and cancer. Our health is closely associated with the state of our microbiota, and their homeostasis. The aim of this review is to describe the associations between human gut microbiota and cancer, and examine the potential role of gut microbiota in anticancer therapy.

scholarly journals Gut Microbiota Bacterial Species Associated with Mediterranean Diet-Related Food Groups in a Northern Spanish Population

Nutrients ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 636
Author(s):  
Carles Rosés ◽  
Amanda Cuevas-Sierra ◽  
Salvador Quintana ◽  
José I. Riezu-Boj ◽  
J. Alfredo Martínez ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Dietary Intake ◽  
Mediterranean Diet ◽  
Dietary Habits ◽  
Metabolic Diseases ◽  
Bacterial Species ◽  
Short Chain Fatty Acids ◽  
Normal Weight ◽  
Food Groups ◽  
Statistical Tool

The MD (Mediterranean diet) is recognized as one of the healthiest diets worldwide and is associated with the prevention of cardiovascular and metabolic diseases. Dietary habits are considered one of the strongest modulators of gut microbiota, which seem to play a significant role in health status of the host. The purpose of the present study was to evaluate interactive associations between gut microbiota composition and habitual dietary intake in 360 Spanish adults from the Obekit cohort (normal weight, overweight, and obese participants). Dietary intake and adherence to the MD tests were administered and fecal samples were collected from each participant. Fecal 16S rRNA (ribosomal Ribonucleic Acid) gene sequencing was performed and checked against the dietary habits. MetagenomeSeq was the statistical tool applied to analyze data at the species taxonomic level. Results from this study identified several beneficial bacteria that were more abundant in the individuals with higher adherence to the MD. Bifidobacterium animalis was the species with the strongest association with the MD. Some SCFA (Short Chain Fatty Acids) -producing bacteria were also associated with MD. In conclusion, this study showed that MD, fiber, legumes, vegetable, fruit, and nut intake are associated with an increase in butyrate-producing taxa such as Roseburia faecis, Ruminococcus bromii, and Oscillospira (Flavonifractor) plautii.

scholarly journals In Vitro Digestion and Fermentation by Human Fecal Microbiota of Polysaccharides from Flaxseed

Molecules ◽  
2020 ◽  
Vol 25 (19) ◽  
pp. 4354
Author(s):  
Xin Zhou ◽  
Zhao Zhang ◽  
Fenghong Huang ◽  
Chen Yang ◽  
Qingde Huang
Keyword(s):  
Gut Microbiota ◽  
Reducing Sugars ◽  
In Vitro Digestion ◽  
Short Chain Fatty Acids ◽  
Fecal Microbiota ◽  
Gut Health ◽  
Human Gut ◽  
In Vitro Fermentation ◽  
Composition And Structure

The digestion of flaxseed polysaccharides (FSP) in simulated saliva, gastric and small intestine conditions was assessed, as well as in vitro fermentation of FSP by human gut microbiota. FSP was not degraded in the simulated digestive systems (there was no change in molecular weight or content of reducing sugars), indicating that ingested FSP would reach the large intestine intact. Changes in carbohydrate content, reducing sugars and culture pH suggested that FSP could be broken down and used by gut microbiota. FSP modulated the composition and structure of the gut microbiota by altering the Firmicutes/Bacteroidetes ratio and increasing the relative abundances of Prevotella, Phascolarctobacterium, Clostridium and Megamonas, which can degrade polysaccharides. Meanwhile, FSP fermentation increased the concentration of short-chain fatty acids, especially propionic and butyric acids. Our results indicate that FSP might be developed as a functional food that benefits gut health.

scholarly journals Long-Chain Bases from Sea Cucumber Alleviate Obesity by Modulating Gut Microbiota

Marine Drugs ◽  
2019 ◽  
Vol 17 (8) ◽  
pp. 455 ◽  
Author(s):  
Hu ◽  
Xu ◽  
Gao ◽  
Li ◽  
Jiang ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
High Fat Diet ◽  
Sea Cucumber ◽  
Short Chain Fatty Acids ◽  
Food Supplement ◽  
G Protein Coupled Receptors ◽  
Gut Health ◽  
Human Gut ◽  
G Protein Coupled ◽  
Long Chain

This study evaluated the effects of long-chain bases from sea cucumber (SC-LCBs) on modulation of the gut microbiota and inhibition of obesity in high fat diet-fed mice. Results showed that SC-LCBs exerted significant antiobese effects, which were associated with the inhibition of hyperglycemia and lipid accumulation. SC-LCBs also regulated serum adipocytokines toward to normal levels. SC-LCBs caused significant decreases in Firmicutes, Actinobacteria phylum, and obesity-related bacteria (Desulfovibro, Bifidobacterium, Romboutsia etc. genus). SC-LCBs also elevated Bacteroidetes, Proteobacteria, Verrucomicrobia phylum, and short chain fatty acids (SCFAs)-producing bacteria (Bacteroides, Lactobacillus, Lachnospiraceae_NK4A136_group etc. genus). Moreover, serum and fecal lipoplysaccharide (LPS) concentrations and its dependent toll-line receptor 4 pathway were inhibited by SC-LCBs treatment. SC-LCBs caused increases in fecal SCFAs and their mediated G-protein-coupled receptors proteins. These suggest that SC-LCBs alleviate obesity by altering gut microbiota. Thus, it sought to indicate that SC-LCBs can be developed as food supplement for the obesity control and the human gut health.

scholarly journals Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota

Nutrients ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 206 ◽  
Author(s):  
Umair Shabbir ◽  
Momna Rubab ◽  
Eric Banan-Mwine Daliri ◽  
Ramachandran Chelliah ◽  
Ahsan Javed ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Structural Changes ◽  
Fruits And Vegetables ◽  
Metabolic Diseases ◽  
Structural Diversity ◽  
Gut Health ◽  
Naturally Occurring ◽  
Metabolic Reactions ◽  
Obesity Hypertension

Polyphenols (PPs) are the naturally occurring bioactive components in fruits and vegetables, and they are the most abundant antioxidant in the human diet. Studies are suggesting that ingestion of PPs might be helpful to ameliorate metabolic syndromes that may contribute in the prevention of several chronic disorders like diabetes, obesity, hypertension, and colon cancer. PPs have structural diversity which impacts their bioavailability as they accumulate in the large intestine and are extensively metabolized through gut microbiota (GM). Intestinal microbiota transforms PPs into their metabolites to make them bioactive. Interestingly, not only GM act on PPs to metabolize them but PPs also modulate the composition of GM. Thus, change in GM from pathogenic to beneficial ones may be helpful to ameliorate gut health and associated diseases. However, to overcome the low bioavailability of PPs, various approaches have been developed to improve their solubility and transportation through the gut. In this review, we present evidence supporting the structural changes that occur after metabolic reactions in PPs (curcumin, quercetin, and catechins) and their effect on GM composition that leads to improving overall gut health and helping to ameliorate metabolic disorders.

scholarly journals The Controversial Role of Human Gut Lachnospiraceae

2020 ◽  
Vol 8 (4) ◽  
pp. 573 ◽  
Author(s):  
Mirco Vacca ◽  
Giuseppe Celano ◽  
Francesco Maria Calabrese ◽  
Piero Portincasa ◽  
Marco Gobbetti ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Gut Microbiota ◽  
Short Chain Fatty Acids ◽  
Intestinal Lumen ◽  
Human Gut ◽  
The Core ◽  
Host Diet ◽  
Health And Disease ◽  
Host Physiology

The complex polymicrobial composition of human gut microbiota plays a key role in health and disease. Lachnospiraceae belong to the core of gut microbiota, colonizing the intestinal lumen from birth and increasing, in terms of species richness and their relative abundances during the host’s life. Although, members of Lachnospiraceae are among the main producers of short-chain fatty acids, different taxa of Lachnospiraceae are also associated with different intra- and extraintestinal diseases. Their impact on the host physiology is often inconsistent across different studies. Here, we discuss changes in Lachnospiraceae abundances according to health and disease. With the aim of harnessing Lachnospiraceae to promote human health, we also analyze how nutrients from the host diet can influence their growth and how their metabolites can, in turn, influence host physiology.

Vascular effects of the Mediterranean diet—Part II: Role of omega-3 fatty acids and olive oil polyphenols

2014 ◽  
Vol 63 (3) ◽  
pp. 127-134 ◽  
Author(s):  
Egeria Scoditti ◽  
Cristiano Capurso ◽  
Antonio Capurso ◽  
Marika Massaro
Keyword(s):  
Fatty Acids ◽  
Olive Oil ◽  
Mediterranean Diet ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Vascular Effects ◽  
The Mediterranean

scholarly journals Gut Microbiota-Dependent Modulation of Energy Metabolism

2017 ◽  
Vol 10 (3) ◽  
pp. 163-171 ◽  
Author(s):  
Christina N. Heiss ◽  
Louise E. Olofsson
Keyword(s):  
Energy Balance ◽  
Gut Microbiota ◽  
Metabolic Diseases ◽  
Short Chain Fatty Acids ◽  
Germ Free ◽  
Diet Induced Obesity ◽  
Obese Subjects ◽  
Microbial Products ◽  
And Storage

The gut microbiota has emerged as an environmental factor that modulates the host's energy balance. It increases the host's ability to harvest energy from the digested food, and produces metabolites and microbial products such as short-chain fatty acids, secondary bile acids, and lipopolysaccharides. These metabolites and microbial products act as signaling molecules that modulate appetite, gut motility, energy uptake and storage, and energy expenditure. Several findings suggest that the gut microbiota can affect the development of obesity. Germ-free mice are leaner than conventionally raised mice and they are protected against diet-induced obesity. Furthermore, obese humans and rodents have an altered gut microbiota composition with less phylogeneic diversity compared to lean controls, and transplantation of the gut microbiota from obese subjects to germ-free mice can transfer the obese phenotype. Taken together, these findings indicate a role for the gut microbiota in obesity and suggest that the gut microbiota could be targeted to improve metabolic diseases like obesity. This review focuses on the role of the gut microbiota in energy balance regulation and its potential role in obesity.

Sign in / Sign up

Export Citation Format

Share Document